Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Entera Bio Ltd., a foreign private issuer, covers the month of November 2019. The report, dated November 21, 2019, consists solely of a press release issued on that date, which is attached as Exhibit 99.1 and incorporated by reference.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. As this report is a vehicle for a press release rather than a financial statement, no quantitative financial data is included in the provided content.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The document serves only to reference an external press release without detailing specific operational or financial shifts within the text itself.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are contained within the referenced press release (Exhibit 99.1) but are not summarized in the body of this Form 6-K.
Key Facts for Investor Verification
- The filing is a procedural report incorporating a press release dated November 21, 2019.
- No financial data or operational metrics are present in the filing text itself.
- Investors must review Exhibit 99.1 (the press release) to understand the specific announcement or event triggering this filing.
- The registrant is headquartered in Jerusalem, Israel, and files annual reports on Form 20-F.